Physician profile
Roger J Nagy
NPI 1093780165
$12,574.14
in general payments reported to CMS, 2019-2025
14 companies · $484 in 2025
The $484 reported for 2025 was more than what a typical Surgical Critical Care provider received nationally (typical 2025 total: $234).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.66 · 2020: $31.33 · 2021: $14.88 · 2022: $11K · 2023: $289 · 2024: $480 · 2025: $484.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,243 · Education: $10.22.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,242.58 |
| Education | $10.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $11,818.49 | 2022-2025 | Da Vinci Surgical System |
| Tela Bio, INC. | $422.92 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kls-Martin L.P. | $58.75 | 2022-2023 | |
| Medtronic, INC. | $47.88 | 2023 | Signia, Progrip |
| Integra Lifesciences Corporation | $41.13 | 2025 | Integra, Surgimend, Integra Dermal Regeneration Template |
| Takeda Pharmaceuticals U.S.A., INC. | $34.62 | 2021-2022 | |
| Conmed Corporation | $24.36 | 2022 | |
| Kerecis Limited | $23.87 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Arjo INC. | $20.13 | 2024 | |
| Portola Pharmaceuticals, LLC | $17.66 | 2019 | |
| Ethicon US, LLC | $17.00 | 2025 | Monocryl, Dermabond Prineo, Stratafix |
| Acell, INC. | $16.92 | 2020 | |
| Abbott Laboratories | $16.00 | 2022 | |
| Allergan, INC. | $14.41 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Roger Nagy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.